Cabaletta Bio (CABA) Share-based Compensation (2018 - 2026)

Cabaletta Bio's Share-based Compensation history runs 8 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• In Q4 2025, Share-based Compensation rose 237.75% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $9.1 million (up 334.22% YoY), while the FY2025 annual figure was $20.9 million, up 91.0% from the prior year.
• Share-based Compensation for Q4 2025 stood at $4.3 million, down from $38.7 million in the prior quarter.
• The five-year high for Share-based Compensation was $47.4 million in Q2 2025, with the low at -$6.2 million in Q4 2023.
• The 5-year median for Share-based Compensation is $1.6 million (2021), against an average of $5.7 million.
• The sharpest annual moves came in 2023 and 2024: Share-based Compensation plunged 495.69% in 2023, then soared 173535.06% in 2024.
• Cabaletta Bio's Share-based Compensation stood at $1.6 million in 2021, then fell by 1.44% to $1.6 million in 2022, then slumped by 495.69% to -$6.2 million in 2023, then jumped by 50.5% to -$3.1 million in 2024, then soared by 237.75% to $4.3 million in 2025.
• Business Quant data shows CABA's Share-based Compensation at $4.3 million in Q4 2025, $38.7 million in Q3 2025, and $47.4 million in Q2 2025.